BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20413846)

  • 1. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
    Martin LJ
    Pharmaceuticals (Basel); 2010; 3(4):839-915. PubMed ID: 21258649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial pathobiology in ALS.
    Martin LJ
    J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of mitochondria in neurodegenerative diseases.
    Martin LJ
    Prog Mol Biol Transl Sci; 2012; 107():355-415. PubMed ID: 22482456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
    Shi P; Wei Y; Zhang J; Gal J; Zhu H
    J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial degeneration in amyotrophic lateral sclerosis.
    Xu Z; Jung C; Higgins C; Levine J; Kong J
    J Bioenerg Biomembr; 2004 Aug; 36(4):395-9. PubMed ID: 15377878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
    Martin LJ
    Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and amyotrophic lateral sclerosis.
    Hervias I; Beal MF; Manfredi G
    Muscle Nerve; 2006 May; 33(5):598-608. PubMed ID: 16372325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitochondria in amyotrophic lateral sclerosis.
    Swerdlow RH; Parks JK; Pattee G; Parker WD
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):185-90. PubMed ID: 11464951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.